About Theragenics
Theragenics is a company based in Buford (United States) founded in 1981 was acquired by Juniper Investment Company in August 2013.. Theragenics has raised $9.44 million across 3 funding rounds from investors including Wingspire Capital and Juniper Investment Company. Theragenics has completed 3 acquisitions, including CP Medical, GaltNeedleTech and NeedleTech. Theragenics offers products and services including TheraSeed, AgX100, Cesium-131, and Pursue Hydrophilic Guidewire. Theragenics operates in a competitive market with competitors including Koya Medical, Sensus Healthcare, CivaTech Oncology, C4 Imaging and Concure Oncology, among others.
- Headquarter Buford, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Theragenics Corp
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.44 M (USD)
in 3 rounds
-
Latest Funding Round
$40 M (USD), Debt – Conventional
Nov 11, 2021
-
Investors
Wingspire Capital
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
CP Medical
& 2 more
-
Acquired by
Juniper Investment Company
(Aug 05, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Theragenics
Theragenics offers a comprehensive portfolio of products and services, including TheraSeed, AgX100, Cesium-131, and Pursue Hydrophilic Guidewire. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Palladium-103 seeds for prostate cancer treatment.
Iodine-125 implants for localized cancer therapies.
Radioisotope for seamless global delivery solutions.
Guidewire for improving vascular access outcomes.
Funding Insights of Theragenics
Theragenics has successfully raised a total of $9.44M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $40 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $40.0M
-
First Round
First Round
(01 May 2005)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Debt – Conventional - Theragenics | Valuation |
investors |
|
| Aug, 2006 | Amount | Series A - Theragenics | Valuation |
investors |
|
| May, 2005 | Amount | Series A - Theragenics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Theragenics
Theragenics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Wingspire Capital and Juniper Investment Company. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides customized loans and financing to middle market firms worldwide.
|
Founded Year | Domain | Location | |
|
Invests in under-followed small cap US companies and engages management for strategy execution.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Theragenics
Theragenics has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include CP Medical, GaltNeedleTech and NeedleTech. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufactures private label and branded surgical solutions for medical and veterinary markets
|
2001 | ||||
|
Medical devices manufacturer
|
1991 | ||||
|
Provider of insurance broking services for corporate, commercial, and personal clients
|
1991 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Theragenics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Theragenics Comparisons
Competitors of Theragenics
Theragenics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Koya Medical, Sensus Healthcare, CivaTech Oncology, C4 Imaging and Concure Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of smart wearable compression technology for lymphedema and venous diseases
|
|
| domain | founded_year | HQ Location |
Non-invasive skin cancer treatments are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Polymer-based devices for low-dose brachytherapy in solid tumors are provided.
|
|
| domain | founded_year | HQ Location |
Image-guided procedures for prostate cancer treatment are provided.
|
|
| domain | founded_year | HQ Location |
Breast microseed radiotherapy for early-stage breast cancer is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Theragenics
Frequently Asked Questions about Theragenics
When was Theragenics founded?
Theragenics was founded in 1981 and raised its 1st funding round 24 years after it was founded.
Where is Theragenics located?
Theragenics is headquartered in Buford, United States. It is registered at Buford, Georgia, United States.
Who is the current CEO of Theragenics?
Francis Tarallo is the current CEO of Theragenics.
Is Theragenics a funded company?
Theragenics is a funded company, having raised a total of $9.44M across 3 funding rounds to date. The company's 1st funding round was a Series A of $6.25M, raised on May 01, 2005.
What does Theragenics do?
Theragenics Corporation is a medical device company that focuses on the cancer treatment and surgical markets. It manufactures and markets brachytherapy seeding devices that are used in the minimally invasive treatment of localized prostate cancer and of early-stage breast cancer. Its surgical products Also manufactures and distributes surgical products especially wound closure devices, needles and other surgical products. Clients include equipment manufacturers, a network of distributors, and directly to healthcare providers and group purchasing organizations. Has acquired the U.S. and Canadian seed business of Eckert Ziegler BEBIG.
Who are the top competitors of Theragenics?
Theragenics's top competitors include Koya Medical, Sensus Healthcare and RadioGel.
What products or services does Theragenics offer?
Theragenics offers TheraSeed, AgX100, Cesium-131, and Pursue Hydrophilic Guidewire.
How many acquisitions has Theragenics made?
Theragenics has made 3 acquisitions, including CP Medical, GaltNeedleTech, and NeedleTech.
Who are Theragenics's investors?
Theragenics has 2 investors. Key investors include Wingspire Capital, and Juniper Investment Company.